homocysteine has been researched along with norethindrone acetate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eviö, S; Tiitinen, A; Turpeinen, U; Ylikorkala, O | 1 |
| Abrahamsen, B; Bladbjerg, EM; Jespersen, J; Klitgaard, NA; Kristensen, SR; Madsen, JS; Stilgren, L | 1 |
| Alatas, E; Demir, S; Kaleli, B; Yildirim, B | 1 |
| Baviera, G; Cancellieri, F; Corrado, F; Crisafulli, A; D'Anna, R; Squadrito, F | 1 |
| Bonassi Machado, R; Chada Baracat, E; Eduardo Fernandes, C; Marcelo Lakryc, E; Rodrigues De Lima, G | 1 |
| Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M | 1 |
| Baracat, EC; Fernandes, CE; Lakryc, EM; Machado, RB; Soares, JM | 1 |
7 trial(s) available for homocysteine and norethindrone acetate
| Article | Year |
|---|---|
Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
Topics: Administration, Cutaneous; Administration, Oral; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Homocysteine; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 2000 |
Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Norethindrone; Norethindrone Acetate; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Postmenopause | 2002 |
Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Fasting; Female; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Probability; Reference Values; Sensitivity and Specificity | 2003 |
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
Topics: C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Genistein; Homocysteine; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phytoestrogens; Postmenopause; Treatment Outcome | 2005 |
Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance.
Topics: Carotid Artery, Common; Double-Blind Method; Estradiol; Female; Homocysteine; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prospective Studies; Pulsatile Flow; Ultrasonography; Vascular Resistance | 2007 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2010 |
What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Topics: Age Factors; Brazil; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Dropouts; Postmenopause; Progestins; Prospective Studies | 2015 |